QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
|
||
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
per share |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer |
☐ | Emerging growth company | ||||
Smaller reporting company |
TERADYNE, INC.
INDEX
Page No. | ||||||
PART I. FINANCIAL INFORMATION | ||||||
Item 1. |
||||||
Condensed Consolidated Balance Sheets as of April 2, 2023 and December 31, 2022 |
1 | |||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
6 | ||||||
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
26 | ||||
Item 3. |
32 | |||||
Item 4. |
33 | |||||
PART II. OTHER INFORMATION | ||||||
Item 1. |
33 | |||||
Item 1A. |
33 | |||||
Item 2. |
34 | |||||
Item 4. |
34 | |||||
Item 6. |
35 |
Item 1: |
Financial Statements |
April 2, 2023 |
December 31, 2022 |
|||||||
|
|
|||||||
(in thousands, except per share amount) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Marketable securities |
||||||||
Accounts receivable, less allowance for credit losses of $ |
||||||||
Inventories, net |
||||||||
Prepayments |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Marketable securities |
||||||||
Deferred tax assets |
||||||||
Retirement plans assets |
||||||||
Other assets |
||||||||
Acquired intangible assets, net |
||||||||
Goodwill |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
LIABILITIES |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued employees’ compensation and withholdings |
||||||||
Deferred revenue and customer advances |
||||||||
Other accrued liabilities |
||||||||
Operating lease liabilities |
||||||||
Income taxes payable |
||||||||
Current debt |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Retirement plans liabilities |
||||||||
Long-term deferred revenue and customer advances |
||||||||
Long-term other accrued liabilities |
||||||||
Deferred tax liabilities |
||||||||
Long-term operating lease liabilities |
||||||||
Long-term incomes taxes payable |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note P) |
||||||||
SHAREHOLDERS’ EQUITY |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Retained earnings |
||||||||
|
|
|
|
|||||
Total shareholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and shareholders’ equity |
$ | $ | ||||||
|
|
|
|
For the Three Months Ended |
||||||||
April 2, |
April 3, |
|||||||
2023 |
2022 |
|||||||
|
|
|||||||
(in thousands, except per share amount) |
||||||||
Revenues: |
||||||||
Products |
$ | $ | ||||||
Services |
||||||||
|
|
|
|
|||||
Total revenues |
||||||||
Cost of revenues: |
||||||||
Cost of products |
||||||||
Cost of services |
||||||||
|
|
|
|
|||||
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
||||||||
|
|
|
|
|||||
Gross profit |
||||||||
Operating expenses: |
||||||||
Selling and administrative |
||||||||
Engineering and development |
||||||||
Acquired intangible assets amortization |
||||||||
Restructuring and other |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Income from operations |
||||||||
Non-operating (income) expense: |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense |
||||||||
Other (income) expense, net |
||||||||
|
|
|
|
|||||
Income before income taxes |
||||||||
Income tax provision |
||||||||
|
|
|
|
|||||
Net income |
$ | $ | ||||||
|
|
|
|
|||||
Net income per common share: |
||||||||
Basic |
$ | $ | ||||||
|
|
|
|
|||||
Diluted |
$ | $ | ||||||
|
|
|
|
|||||
Weighted average common shares—basic |
||||||||
|
|
|
|
|||||
Weighted average common shares—diluted |
||||||||
|
|
|
|
For the Three Months Ended |
||||||||
April 2, |
April 3, |
|||||||
2023 |
2022 |
|||||||
|
|
|||||||
(in thousands) |
||||||||
Net income |
$ | $ | ||||||
Other comprehensive income (loss) , net of tax: |
||||||||
Foreign currency translation adjustment, net of tax of $ |
( |
) | ||||||
Available-for-sale |
||||||||
Unrealized gains (losses) on marketable securities arising during period, net of tax of $ |
( |
) | ||||||
Less: Reclassification adjustment for losses (gains) included in net income, net of tax of $ |
( |
) | ||||||
|
|
|
|
|||||
( |
) | |||||||
Cash flow hedges: |
||||||||
Unrealized gains arising during period, net of tax of $ |
||||||||
Less: Reclassification adjustment for losses included in net income, net of tax of $ |
||||||||
|
|
|
|
|||||
Defined benefit post-retirement plan: |
||||||||
Amortization of prior service credit, net of tax of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Other comprehensive income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Comprehensive income |
$ | $ | ||||||
|
|
|
|
Shareholders’ Equity |
||||||||||||||||||||||||||||
Convertible Common Shares Value |
Common Stock Shares |
Common Stock Par Value |
Additional Paid-in Capital |
Accumulated Other Comprehensive (Loss) Income |
Retained Earnings |
Total Shareholders’ Equity |
||||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||||||
For the Three Months Ended April 2, 2023 |
||||||||||||||||||||||||||||
Balance, December 31, 2022 |
$ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
Net issuance of common stock under stock-based plans |
( |
) | ( |
) | ||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Cash dividends ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) | ||||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) | ( |
) | ||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||
Balance, April 2, 2023 |
$ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
For the Three Months Ended April 3, 2022 |
||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
Net issuance of common stock under stock-based plans |
( |
) | ( |
) | ||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Cash dividends ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) | ( |
) | ||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) | ( |
) | ||||||||||||||||||||||||
Cumulative-effect of change in accounting principle related to convertible debt |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, April 3, 2022 |
$ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
For the Three Months Ended |
||||||||
April 2, |
April 3, |
|||||||
2023 |
2022 |
|||||||
(in thousands) |
||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income from operations to net cash provided by operating activities: |
||||||||
Depreciation |
||||||||
Stock-based compensation |
||||||||
Provision for excess and obsolete inventory |
||||||||
Amortization |
||||||||
Deferred taxes |
( |
) | ||||||
(Gains) losses on investments |
( |
) | ||||||
Other |
||||||||
Changes in operating assets and liabilities |
||||||||
Accounts receivable |
||||||||
Inventories |
( |
) | ( |
) | ||||
Prepayments and other assets |
( |
) | ( |
) | ||||
Accounts payable and other accrued expenses |
( |
) | ( |
) | ||||
Deferred revenue and customer advances |
( |
) | ||||||
Retirement plan contributions |
( |
) | ( |
) | ||||
Income taxes |
( |
) | ||||||
Net cash provided by operating activities |
||||||||
Cash flows from investing activities: |
||||||||
Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
Purchases of marketable securities |
( |
) | ( |
) | ||||
Proceeds from sales of marketable securities |
||||||||
Proceeds from maturities of marketable securities |
||||||||
Proceeds from life insurance |
||||||||
Net cash used for investing activities |
( |
) | ( |
) | ||||
Cash flows from financing activities: |
||||||||
Issuance of common stock under stock purchase and stock option plans |
||||||||
Repurchase of common stock |
( |
) | ( |
) | ||||
Payments related to net settlement of employee stock compensation awards |
( |
) | ( |
) | ||||
Dividend payments |
( |
) | ( |
) | ||||
Payments of convertible debt principal |
( |
) | ( |
) | ||||
Net cash used for financing activities |
( |
) | ( |
) | ||||
Effects of exchange rate changes on cash and cash equivalents |
( |
) | ||||||
Decrease in cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents at beginning of period |
||||||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
Non-cash investing activities: |
||||||||
Capital expenditures incurred but not yet paid: |
$ | $ |
• | semiconductor test (“Semiconductor Test”) systems; |
• | storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
• | wireless test (“Wireless Test”) systems; and |
• | robotics (“Robotics”) products. |
Semiconductor Test |
Robotics |
|||||||||||||||||||||||||||||||
System on- a-Chip |
Memory |
System Test |
Universal Robots |
Mobile Industrial Robots |
Wireless Test |
Corporate and Eliminations |
Total |
|||||||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||||||||||
For the Three Months Ended April 2, 2023 (1) |
||||||||||||||||||||||||||||||||
Timing of Revenue Recognition |
||||||||||||||||||||||||||||||||
Point in Time |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Over Time |
— | |||||||||||||||||||||||||||||||
Total |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Geographical Market |
||||||||||||||||||||||||||||||||
Asia Pacific |
$ | $ | $ | $ | $ | $ | $ | — | $ | |||||||||||||||||||||||
Americas |
||||||||||||||||||||||||||||||||
Europe, Middle East and Africa |
— | |||||||||||||||||||||||||||||||
Total |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
For the Three Months Ended April 3, 2022 (1) |
||||||||||||||||||||||||||||||||
Timing of Revenue Recognition |
||||||||||||||||||||||||||||||||
Point in Time |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
Over Time |
— | |||||||||||||||||||||||||||||||
Total |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
Geographical Market |
||||||||||||||||||||||||||||||||
Asia Pacific |
$ | $ | $ | $ | $ | $ | $ | — | $ | |||||||||||||||||||||||
Americas |
( |
) | ||||||||||||||||||||||||||||||
Europe, Middle East and Africa |
— | |||||||||||||||||||||||||||||||
Total |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||
(1) | Includes $ “Revenue from Contracts with Customers.” |
April 2, 2023 |
December 31, 2022 |
|||||||
(in thousands) |
||||||||
Maintenance, service and training |
$ | $ | ||||||
Extended warranty |
||||||||
Customer advances, undelivered elements and other |
||||||||
Total deferred revenue and customer advances |
$ | $ | ||||||
April 2, 2023 |
December 31, 2022 |
|||||||
(in thousands) |
||||||||
Raw material |
$ | $ | ||||||
Work-in-process |
||||||||
Finished goods |
||||||||
$ | $ | |||||||
April 2, 2023 |
||||||||||||||||
Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total |
|||||||||||||
(in thousands) |
||||||||||||||||
Assets |
||||||||||||||||
Cash |
$ | $ | $ | $ | ||||||||||||
Cash equivalents |
||||||||||||||||
Available-for-sale |
||||||||||||||||
U.S. Treasury securities |
||||||||||||||||
Corporate debt securities |
||||||||||||||||
Commercial paper |
||||||||||||||||
U.S. government agency securities |
||||||||||||||||
Debt mutual funds |
||||||||||||||||
Certificates of deposit and time deposits |
||||||||||||||||
Non-U.S. government securities |
||||||||||||||||
Equity securities: |
||||||||||||||||
Mutual funds |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Derivative liabilities |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
(Level 1) |
(Level 2) |
(Level 3) |
Total |
|||||||||||||
(in thousands) |
||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Marketable securities |
||||||||||||||||
Long-term marketable securities |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Other current liabilities |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
December 31, 2022 |
||||||||||||||||
Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total |
|||||||||||||
(in thousands) |
||||||||||||||||
Assets |
||||||||||||||||
Cash |
$ | $ | $ | $ | ||||||||||||
Cash equivalents |
||||||||||||||||
Available for sale securities: |
||||||||||||||||
Corporate debt securities |
||||||||||||||||
U.S. Treasury securities |
||||||||||||||||
Commercial paper |
||||||||||||||||
Debt mutual funds |
||||||||||||||||
U.S. government agency securities |
||||||||||||||||
Certificates of deposit and time deposits |
||||||||||||||||
Non-U.S. government securities |
||||||||||||||||
Equity securities: |
||||||||||||||||
Mutual funds |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Derivative assets |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Derivative liabilities |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
(Level 1) |
(Level 2) |
(Level 3) |
Total |
|||||||||||||
(in thousands) |
||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Marketable securities |
||||||||||||||||
Long-term marketable securities |
||||||||||||||||
Prepayments |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Other current liabilities |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
April 2, 2023 |
December 31, 2022 |
|||||||||||||||
Carrying Value |
Fair Value |
Carrying Value |
Fair Value |
|||||||||||||
(in thousands) |
||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Marketable securities |
||||||||||||||||
Liabilities |
||||||||||||||||
Convertible debt |
April 2, 2023 |
||||||||||||||||||||
Available-for-Sale |
||||||||||||||||||||
Cost |
Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
U.S. Treasury securities |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
Corporate debt securities |
( |
) | ||||||||||||||||||
Commercial paper |
( |
) | ||||||||||||||||||
U.S. government agency securities |
( |
) | ||||||||||||||||||
Debt mutual funds |
— | ( |
) |